Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Slc7a2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC7A2 mRNA | CTD | PMID:36331819 | 17alpha-ethynylestradiol | multiple interactions | ISO | Slc7a2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC7A2 mRNA | CTD | PMID:17942748 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of SLC7A2 mRNA | CTD | PMID:17404688 | 17beta-estradiol | affects expression | ISO | Slc7a2 (Rattus norvegicus) | 6480464 | Estradiol affects the expression of SLC7A2 mRNA | CTD | PMID:32145629 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of SLC7A2 mRNA | CTD | PMID:19167446 more ... | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of SLC7A2 mRNA | CTD | PMID:21185374 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Slc7a2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin affects the methylation of SLC7A2 intron] which results in decreased expression of SLC7A2 mRNA and [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC7A2 mRNA | CTD | PMID:17942748 and PMID:33017471 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Slc7a2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC7A2 mRNA | CTD | PMID:21570461 more ... | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Slc7a2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC7A2 mRNA | CTD | PMID:21215274 more ... | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Slc7a2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC7A2 mRNA | CTD | PMID:22298810 and PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC7A2 mRNA | CTD | PMID:19770486 and PMID:19933214 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | ISO | Slc7a2 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | ISO | Slc7a2 (Mus musculus) | 6480464 | 3 more ... | CTD | PMID:19467301 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | tetrabromobisphenol A results in decreased expression of SLC7A2 mRNA | CTD | PMID:25172293 | 3-Iodothyronamine | affects uptake | EXP | | 6480464 | SLC7A2 mRNA affects the uptake of 3-iodothyronamine | CTD | PMID:19074582 | 4,4'-diaminodiphenylmethane | increases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of SLC7A2 mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | increases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | bisphenol S results in increased expression of SLC7A2 mRNA | CTD | PMID:30951980 | 4-hydroxynon-2-enal | decreases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of SLC7A2 mRNA | CTD | PMID:19191707 | acetamide | decreases expression | ISO | Slc7a2 (Rattus norvegicus) | 6480464 | acetamide results in decreased expression of SLC7A2 mRNA | CTD | PMID:31881176 | acrolein | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of SLC7A2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of SLC7A2 mRNA | CTD | PMID:32699268 | aflatoxin B1 | decreases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of SLC7A2 mRNA | CTD | PMID:19770486 | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of SLC7A2 gene | CTD | PMID:27153756 | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of SLC7A2 mRNA | CTD | PMID:27153756 | aldrin | decreases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | Aldrin results in decreased expression of SLC7A2 mRNA | CTD | PMID:18579281 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of SLC7A2 mRNA | CTD | PMID:21934132 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of SLC7A2 mRNA | CTD | PMID:15894607 and PMID:33167477 | alpha-pinene | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of SLC7A2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of SLC7A2 mRNA | CTD | PMID:32699268 | ammonium chloride | affects expression | ISO | Slc7a2 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of SLC7A2 mRNA | CTD | PMID:16483693 | amphetamine | decreases expression | ISO | Slc7a2 (Rattus norvegicus) | 6480464 | Amphetamine results in decreased expression of SLC7A2 mRNA | CTD | PMID:30779732 | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of SLC7A2 mRNA | CTD | PMID:33212167 | arsane | multiple interactions | ISO | Slc7a2 (Mus musculus) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SLC7A2 mRNA | CTD | PMID:32045263 | arsenic atom | multiple interactions | ISO | Slc7a2 (Mus musculus) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SLC7A2 mRNA | CTD | PMID:32045263 | arsenite(3-) | decreases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | arsenite results in decreased expression of SLC7A2 mRNA | CTD | PMID:18929588 | arsenite(3-) | multiple interactions | ISO | Slc7a2 (Mus musculus) | 6480464 | TRP53 protein affects the reaction [arsenite results in decreased expression of SLC7A2 mRNA] | CTD | PMID:18929588 | benzo[a]pyrene | decreases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of SLC7A2 mRNA | CTD | PMID:19770486 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of SLC7A2 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of SLC7A2 promoter | CTD | PMID:27901495 | bis(2-ethylhexyl) phthalate | increases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of SLC7A2 mRNA | CTD | PMID:35550907 | bisphenol A | increases expression | ISO | Slc7a2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of SLC7A2 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of SLC7A2 mRNA | CTD | PMID:32156529 | bisphenol A | affects expression | ISO | Slc7a2 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of SLC7A2 mRNA | CTD | PMID:32145629 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A analog results in increased expression of SLC7A2 mRNA and bisphenol A results in increased expression of SLC7A2 mRNA | CTD | PMID:32387340 more ... | bisphenol A | increases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of SLC7A2 mRNA | CTD | PMID:30951980 | Bisphenol B | increases expression | EXP | | 6480464 | bisphenol B results in increased expression of SLC7A2 mRNA | CTD | PMID:32387340 | bisphenol F | increases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | bisphenol F results in increased expression of SLC7A2 mRNA | CTD | PMID:30951980 | calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of SLC7A2 mRNA | CTD | PMID:21592394 | calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of SLC7A2 mRNA | CTD | PMID:21592394 | carbon nanotube | increases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in increased expression of SLC7A2 mRNA | CTD | PMID:25554681 | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SLC7A2 gene] | CTD | PMID:28238834 | choline | multiple interactions | ISO | Slc7a2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SLC7A2 mRNA | CTD | PMID:20938992 | ciguatoxin CTX1B | affects expression | ISO | Slc7a2 (Mus musculus) | 6480464 | Ciguatoxins affects the expression of SLC7A2 mRNA | CTD | PMID:18353800 | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of SLC7A2 mRNA | CTD | PMID:27594783 | clofibrate | multiple interactions | ISO | Slc7a2 (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of SLC7A2 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SLC7A2 mRNA] | CTD | PMID:17585979 | clofibrate | decreases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of SLC7A2 mRNA | CTD | PMID:17585979 | clofibric acid | multiple interactions | ISO | Slc7a2 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SLC7A2 mRNA | CTD | PMID:17602206 | copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of SLC7A2 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of SLC7A2 mRNA | CTD | PMID:20971185 | copper(II) sulfate | decreases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | Copper Sulfate results in decreased expression of SLC7A2 mRNA | CTD | PMID:18579281 | crocidolite asbestos | affects expression | EXP | | 6480464 | Asbestos and Crocidolite affects the expression of SLC7A2 mRNA | CTD | PMID:24160326 and PMID:25757056 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of SLC7A2 mRNA | CTD | PMID:20106945 and PMID:27989131 | cyclosporin A | affects expression | EXP | | 6480464 | Cyclosporine affects the expression of SLC7A2 mRNA | CTD | PMID:25562108 | cyclosporin A | decreases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | Cyclosporine results in decreased expression of SLC7A2 mRNA | CTD | PMID:19770486 | cytarabine | decreases expression | EXP | | 6480464 | Cytarabine results in decreased expression of SLC7A2 mRNA | CTD | PMID:21198554 | diallyl trisulfide | increases expression | EXP | | 6480464 | diallyl trisulfide results in increased expression of SLC7A2 mRNA | CTD | PMID:34995734 | dieldrin | decreases expression | ISO | Slc7a2 (Rattus norvegicus) | 6480464 | Dieldrin results in decreased expression of SLC7A2 mRNA | CTD | PMID:23153324 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | endosulfan | decreases expression | ISO | Slc7a2 (Rattus norvegicus) | 6480464 | Endosulfan results in decreased expression of SLC7A2 mRNA | CTD | PMID:29391264 | epoxiconazole | decreases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of SLC7A2 mRNA | CTD | PMID:35436446 | ethanol | increases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | Ethanol results in increased expression of SLC7A2 mRNA | CTD | PMID:30319688 | flavonoids | decreases expression | ISO | Slc7a2 (Rattus norvegicus) | 6480464 | Flavonoids results in decreased expression of SLC7A2 mRNA | CTD | PMID:18035473 | folic acid | multiple interactions | ISO | Slc7a2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SLC7A2 mRNA | CTD | PMID:20938992 | furan | increases methylation | ISO | Slc7a2 (Rattus norvegicus) | 6480464 | furan results in increased methylation of SLC7A2 gene | CTD | PMID:22079235 | gamma-hexachlorocyclohexane | increases expression | ISO | Slc7a2 (Rattus norvegicus) | 6480464 | Hexachlorocyclohexane results in increased expression of SLC7A2 mRNA | CTD | PMID:17785943 | genistein | increases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | Genistein results in increased expression of SLC7A2 mRNA | CTD | PMID:32186404 | gentamycin | decreases expression | ISO | Slc7a2 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of SLC7A2 mRNA | CTD | PMID:33387578 | heptachlor | decreases expression | ISO | Slc7a2 (Rattus norvegicus) | 6480464 | Heptachlor results in decreased expression of SLC7A2 mRNA | CTD | PMID:23153324 | inulin | multiple interactions | ISO | Slc7a2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SLC7A2 mRNA | CTD | PMID:36331819 | L-methionine | multiple interactions | ISO | Slc7a2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SLC7A2 mRNA | CTD | PMID:20938992 | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of SLC7A2 mRNA | CTD | PMID:28988120 | lipopolysaccharide | increases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | Lipopolysaccharides results in increased expression of SLC7A2 mRNA | CTD | PMID:23415871 | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of SLC7A2 mRNA | CTD | PMID:35811015 | lipopolysaccharide | multiple interactions | EXP | | 6480464 | S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of SLC7A2 mRNA] | CTD | PMID:35811015 | medroxyprogesterone acetate | increases expression | EXP | | 6480464 | Medroxyprogesterone Acetate results in increased expression of SLC7A2 mRNA | CTD | PMID:20843944 | mercury atom | decreases expression | EXP | | 6480464 | Mercury results in decreased expression of SLC7A2 mRNA | CTD | PMID:19937285 | mercury dibromide | increases expression | EXP | | 6480464 | mercuric bromide results in increased expression of SLC7A2 mRNA | CTD | PMID:26272509 | mercury dibromide | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A2 mRNA | CTD | PMID:27188386 | mercury(0) | decreases expression | EXP | | 6480464 | Mercury results in decreased expression of SLC7A2 mRNA | CTD | PMID:19937285 | methapyrilene | decreases expression | ISO | Slc7a2 (Rattus norvegicus) | 6480464 | Methapyrilene results in decreased expression of SLC7A2 mRNA | CTD | PMID:30467583 | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of SLC7A2 mRNA | CTD | PMID:23179753 | mirex | decreases expression | ISO | Slc7a2 (Rattus norvegicus) | 6480464 | Mirex results in decreased expression of SLC7A2 mRNA | CTD | PMID:23153324 | N-nitrosodiethylamine | multiple interactions | ISO | Slc7a2 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SLC7A2 mRNA | CTD | PMID:17602206 | nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of SLC7A2 mRNA | CTD | PMID:17312168 | ozone | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of SLC7A2 mRNA more ... | CTD | PMID:32699268 | paracetamol | multiple interactions | ISO | Slc7a2 (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of SLC7A2 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SLC7A2 mRNA] | CTD | PMID:17585979 | paracetamol | decreases expression | ISO | Slc7a2 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of SLC7A2 mRNA | CTD | PMID:33387578 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of SLC7A2 mRNA | CTD | PMID:21420995 | parathion | increases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | Parathion results in increased expression of SLC7A2 mRNA | CTD | PMID:34813904 | perfluorohexanesulfonic acid | decreases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of SLC7A2 mRNA | CTD | PMID:37995155 | perfluorononanoic acid | increases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in increased expression of SLC7A2 mRNA | CTD | PMID:32588087 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Slc7a2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC7A2 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SLC7A2 mRNA | CTD | PMID:36331819 | phenobarbital | multiple interactions | ISO | Slc7a2 (Mus musculus) | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of SLC7A2 mRNA] | CTD | PMID:19482888 | phenobarbital | decreases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | Phenobarbital results in decreased expression of SLC7A2 mRNA | CTD | PMID:19482888 and PMID:23091169 | phenobarbital | increases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of SLC7A2 mRNA | CTD | PMID:19270015 | phenylmercury acetate | increases expression | EXP | | 6480464 | Phenylmercuric Acetate results in increased expression of SLC7A2 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A2 mRNA | CTD | PMID:27188386 | picene | decreases expression | EXP | | 6480464 | picene results in decreased expression of SLC7A2 mRNA | CTD | PMID:32251684 | pirinixic acid | multiple interactions | ISO | Slc7a2 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC7A2 mRNA | CTD | PMID:19710929 | pirinixic acid | increases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of SLC7A2 mRNA | CTD | PMID:18445702 | progesterone | multiple interactions | EXP | | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of SLC7A2 mRNA | CTD | PMID:17404688 | propiconazole | decreases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | propiconazole results in decreased expression of SLC7A2 mRNA | CTD | PMID:21278054 | resveratrol | multiple interactions | ISO | Slc7a2 (Mus musculus) | 6480464 | Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of SLC7A2 mRNA] | CTD | PMID:31298478 | rotenone | increases expression | ISO | Slc7a2 (Rattus norvegicus) | 6480464 | Rotenone results in increased expression of SLC7A2 mRNA | CTD | PMID:28374803 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of SLC7A2 mRNA] | CTD | PMID:35811015 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | serpentine asbestos | affects expression | EXP | | 6480464 | Asbestos and Serpentine affects the expression of SLC7A2 mRNA | CTD | PMID:24160326 | sevoflurane | affects expression | ISO | Slc7a2 (Rattus norvegicus) | 6480464 | sevoflurane affects the expression of SLC7A2 mRNA | CTD | PMID:15967596 | silver atom | decreases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | Silver results in decreased expression of SLC7A2 mRNA | CTD | PMID:27131904 | silver(0) | decreases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | Silver results in decreased expression of SLC7A2 mRNA | CTD | PMID:27131904 | sodium arsenite | multiple interactions | ISO | Slc7a2 (Mus musculus) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SLC7A2 mRNA | CTD | PMID:32045263 | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of SLC7A2 mRNA | CTD | PMID:31533062 | T-2 toxin | decreases expression | EXP | | 6480464 | T-2 Toxin results in decreased expression of SLC7A2 mRNA | CTD | PMID:31863870 | testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of SLC7A2 mRNA | CTD | PMID:21592394 | testosterone | decreases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | Testosterone results in decreased expression of SLC7A2 mRNA | CTD | PMID:20403060 and PMID:21669218 | testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of SLC7A2 mRNA | CTD | PMID:21592394 | tetrachloromethane | decreases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of SLC7A2 mRNA | CTD | PMID:31919559 | titanium dioxide | multiple interactions | ISO | Slc7a2 (Mus musculus) | 6480464 | Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of SLC7A2 mRNA] | CTD | PMID:31298478 | titanium dioxide | decreases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of SLC7A2 mRNA | CTD | PMID:31298478 | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of SLC7A2 mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A2 mRNA | CTD | PMID:27188386 | Triptolide | decreases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | triptolide results in decreased expression of SLC7A2 mRNA | CTD | PMID:32835833 | troglitazone | decreases expression | ISO | Slc7a2 (Mus musculus) | 6480464 | troglitazone results in decreased expression of SLC7A2 mRNA | CTD | PMID:28973697 | trovafloxacin | multiple interactions | ISO | Slc7a2 (Mus musculus) | 6480464 | [trovafloxacin co-treated with lipopolysaccharide and E coli O55-B5] results in increased expression of SLC7A2 mRNA | CTD | PMID:18930950 | valproic acid | decreases methylation | EXP | | 6480464 | Valproic Acid results in decreased methylation of SLC7A2 gene | CTD | PMID:29154799 | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A2 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of SLC7A2 mRNA | CTD | PMID:23179753 more ... | valproic acid | affects expression | ISO | Slc7a2 (Mus musculus) | 6480464 | Valproic Acid affects the expression of SLC7A2 mRNA | CTD | PMID:17963808 | zearalenone | increases expression | EXP | | 6480464 | Zearalenone results in increased expression of SLC7A2 mRNA | CTD | PMID:36828454 | zidovudine | decreases expression | EXP | | 6480464 | Zidovudine results in decreased expression of SLC7A2 mRNA | CTD | PMID:24292225 | zoledronic acid | decreases expression | EXP | | 6480464 | zoledronic acid results in decreased expression of SLC7A2 mRNA | CTD | PMID:24714768 | |